Royal Bank of Canada’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.8M Sell
551,109
-6,420
-1% -$385K 0.01% 1210
2025
Q4
$32.8M Sell
557,529
-172,464
-24% -$10.5M 0.01% 1156
2025
Q3
$40.6M Buy
729,993
+34,698
+5% +$1.86M 0.01% 1132
2025
Q2
$35.8M Buy
695,295
+398,721
+134% +$20M 0.01% 1138
2025
Q1
$17.4M Sell
296,574
-93,248
-24% -$6.32M ﹤0.01% 1388
2024
Q4
$28.1M Buy
389,822
+8,626
+2% +$633K 0.01% 1149
2024
Q3
$30.5M Buy
381,196
+13,302
+4% +$1,000K 0.01% 1087
2024
Q2
$26.4M Sell
367,894
-89,346
-20% -$6.58M 0.01% 1105
2024
Q1
$32.2M Buy
457,240
+21,417
+5% +$1.53M 0.01% 986
2023
Q4
$33.6M Buy
435,823
+24,362
+6% +$1.6M 0.01% 971
2023
Q3
$28M Buy
411,461
+6,600
+2% +$521K 0.01% 983
2023
Q2
$33M Buy
404,861
+13,959
+4% +$1.12M 0.01% 899
2023
Q1
$29M Sell
390,902
-235,130
-38% -$18.1M 0.01% 915
2022
Q4
$51.9M Buy
626,032
+22,600
+4% +$1.79M 0.01% 673
2022
Q3
$42.8M Sell
603,432
-58,664
-9% -$5.07M 0.01% 702
2022
Q2
$57.4M Sell
662,096
-16,936
-2% -$1.59M 0.02% 614
2022
Q1
$73.5M Buy
679,032
+740
+0.1% +$76.3K 0.02% 606
2021
Q4
$87.7M Sell
678,292
-2,404
-0.4% -$295K 0.02% 575
2021
Q3
$82.5M Buy
680,696
+33,240
+5% +$4.05M 0.02% 558
2021
Q2
$72.9M Sell
647,456
-724
-0.1% -$76.2K 0.02% 588
2021
Q1
$61.9M Sell
648,180
-6,064
-0.9% -$553K 0.02% 608
2020
Q4
$51.9M Buy
654,244
+14,236
+2% +$1.03M 0.02% 697
2020
Q3
$39.6M Buy
640,008
+35,756
+6% +$2.33M 0.01% 721
2020
Q2
$39.9M Sell
604,252
-30,388
-5% -$1.82M 0.02% 663
2020
Q1
$30.1M Buy
634,640
+2,244
+0.4% +$112K 0.01% 697
2019
Q4
$34.7M Buy
632,396
+43,720
+7% +$2.29M 0.01% 805
2019
Q3
$28.8M Buy
588,676
+95,468
+19% +$4.79M 0.01% 847
2019
Q2
$25.7M Buy
493,208
+49,956
+11% +$2.52M 0.01% 928
2019
Q1
$22M Buy
443,252
+28,572
+7% +$1.29M 0.01% 1007
2018
Q4
$15M Buy
414,680
+6,904
+2% +$288K 0.01% 1174
2018
Q3
$20.8M Buy
407,776
+278,648
+216% +$12.3M 0.01% 1105
2018
Q2
$4.78M Buy
129,128
+11,116
+9% +$424K ﹤0.01% 2041
2018
Q1
$4.46M Buy
118,012
+19,988
+20% +$706K ﹤0.01% 2072
2017
Q4
$3.17M Sell
98,024
-7,316
-7% -$232K ﹤0.01% 2392
2017
Q3
$3.18M Sell
105,340
-528
-0.5% -$15.7K ﹤0.01% 2316
2017
Q2
$3.11M Sell
105,868
-560
-0.5% -$15.3K ﹤0.01% 2277
2017
Q1
$2.7M Sell
106,428
-2,956
-3% -$76.3K ﹤0.01% 2325
2016
Q4
$2.81M Sell
109,384
-3,752
-3% -$98.6K ﹤0.01% 2319
2016
Q3
$3.1M Sell
113,136
-9,152
-7% -$251K ﹤0.01% 2231
2016
Q2
$3.45M Buy
122,288
+11,780
+11% +$303K ﹤0.01% 2132
2016
Q1
$2.61M Buy
110,508
+12,484
+13% +$275K ﹤0.01% 2259
2015
Q4
$2.21M Buy
98,024
+2,524
+3% +$57.6K ﹤0.01% 2464
2015
Q3
$2.21M Buy
95,500
+56,656
+146% +$1.42M ﹤0.01% 2190
2015
Q2
$957K Buy
38,844
+3,120
+9% +$77.9K ﹤0.01% 2959
2015
Q1
$896K Sell
35,724
-4,236
-11% -$101K ﹤0.01% 2978
2014
Q4
$923K Sell
39,960
-27,140
-40% -$621K ﹤0.01% 2994
2014
Q3
$1.57M Sell
67,100
-32,372
-33% -$759K ﹤0.01% 2508
2014
Q2
$2.3M Sell
99,472
-15,656
-14% -$346K ﹤0.01% 2206
2014
Q1
$2.46M Sell
115,128
-26,216
-19% -$590K ﹤0.01% 2104
2013
Q4
$3.35M Sell
141,344
-11,852
-8% -$257K ﹤0.01% 1930
2013
Q3
$3.07M Buy
153,196
+4,784
+3% +$90.8K ﹤0.01% 1914
2013
Q2
$2.56M Buy
+148,412
New +$2.46M ﹤0.01% 1901

Other funds holding TECH

Royal Bank of Canada's TECH Position: Q1 2026 in Review

Royal Bank of Canada reduced its Bio-Techne (TECH) stake by 1.2% in Q1 2026, selling an estimated $385K and leaving 551,109 shares worth $28.8M. The position accounts for 0.01% of the portfolio, ranked #1210.

Royal Bank of Canada first reported a position in TECH in Q2 2013 and has held it in 52 quarters since. The position peaked at $87.7M in Q4 2021. 583 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Royal Bank of Canada held 551,109 shares of Bio-Techne worth $28.8M as of Q1 2026.
  • Royal Bank of Canada sold 6,420 Bio-Techne shares in Q1 2026, an estimated $385K.
  • Bio-Techne made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1210 holding.
  • Royal Bank of Canada first reported a position in Bio-Techne in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Bio-Techne position peaked at $87.7M in Q4 2021.
  • 583 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.